Document Type : Original Article

Authors

1 Diabetes Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

3 Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

4 Department of Neurology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

5 Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

6 Department of Epidemiology and Biostatistics, School of Public Health, Kashan University of Medical Sciences, Kashan, Iran

7 Department of Epidemiology and Biostatistics, School of Public Health, Lorestan University of Medical Sciences, Khoramabad, Iran

Abstract

BACKGROUND: The burden of stroke can be reduced by controlling its mortality risk factors. We aimed to identify the predictors of mortality within six months after ischemic stroke.
METHODS: This prospective cohort study was performed on 703 ischemic stroke patients in Tehran, Iran, during 2018–2019. Data on demographic and clinical characteristics were collected through interviews and hospital records. The patients’ survival status was followed up by telephone interviews at 28 days, 3 months, and 6 months after stroke. Cox proportional hazard model and extended Cox model were used to determine the predictors of mortality after stroke.
RESULTS: The 6-month mortality rate was 19.50% (95% CI: 16.70–22.67). Age (HR=1.01; 95% CI: 1.001–1.03), higher educational levels (HR=1.05; 95% CI: 1.01–1.10), and blood sugar levels on admission (HR=1.04; 95% CI: 1.01–1.08) were significantly associated with an increase in 6-month mortality. However, alcohol consumption (HR=0.09; 95% CI: 0.02–0.38), alteplase administration (HR=0.65; 95% CI: 0.43–0.98), and higher hemoglobin values (HR=0.80; 95% CI: 0.72–0.88) were associated with a decrease in 6-month mortality. The hazard ratio of death for diastolic blood pressure, socioeconomic status, cholesterol levels, and stroke severity varied over time.
CONCLUSION: Some characteristics significantly increased or decreased the risk of mortality after stroke. Additionally, the effect of some variables changed over time, suggesting that stroke prognosis may be associated with dynamic risk factors. Identifying and addressing these factors can inform targeted strategies to improve post-stroke survival outcomes.

Keywords

1. Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. Int J Stroke. 2022 Jan;17(1):18-29. https://doi.org/10.1177/17474930211065917
2. Laranjo L, Lanas F, Sun MC, Chen DA, Hynes L, Imran TF, et al. World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update. Glob Heart. 2024 Jan 22;19(1):8. https://doi.org/10.5334/gh.1278
3. Azarpazhooh MR, Etemadi MM, Donnan GA, Mokhber N, Majdi MR, Ghayour-Mobarhan M, et al. Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke. 2010 Jan;41(1):e3-10. https://doi.org/10.1161/strokeaha.109.559708
4. Hosseini AA, Sobhani-Rad D, Ghandehari K, Benamer HT. Frequency and clinical patterns of stroke in Iran - Systematic and critical review. BMC Neurol. 2010 Aug 23;10:72. https://doi.org/10.1186/1471-2377-10-72
5. Schwartz L, Anteby R, Klang E, Soffer S. Stroke mortality prediction using machine learning: systematic review. J Neurol Sci. 2023 Jan 15;444:120529. https://doi.org/10.1016/j.jns.2022.120529
6. Ghandehari K. Epidemiology of stroke in Iran. Galen Med J. 2016;5:e588. https://doi.org/10.31661/gmj.v5i.588
7. Mazaheri S, Beheshti F, Hosseinzadeh A, Mazdeh M, Ghiasian M. Epidemiologic Study of Cardinal Risk Factors of Stroke in Patients who Referred to Farshchian Hospital of Hamadan during 2014-2015. Avicenna J Clin Med 2016; 22 (4) :331-7.
8. Foroozanfar Z, Abdi S, Parsaeian M, Mehrpour M, Gheini M, Fotouhi A. Sex Differences in 28-Day Mortality of Ischemic Stroke in Iran and Its Associated Factors: A Prospective Cohort Study. J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104896. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104896
9. Sartipi M, Nedjat S, Mansournia MA, Baigi V, Fotouhi A. Assets as a Socioeconomic Status Index: Categorical Principal Components Analysis vs. Latent Class Analysis. Arch Iran Med. 2016 Nov;19(11):791-6.
10. Yao T, Zhan Y, Shen J, Xu L, Peng B, Cui Q, et al. Association between fasting blood glucose and outcomes and mortality in acute ischaemic stroke patients with diabetes mellitus: a retrospective observational study in Wuhan, China. BMJ Open. 2020 Jun 23;10(6):e037291. https://doi.org/10.1136/bmjopen-2020-037291
11. Furlan NE, Luvizutto GJ, Hamamoto Filho PT, Zanati Bazan SG, Modolo GP, Ferreira NC, et al. The Impact of Age on Mortality and Disability in Patients With Ischemic Stroke Who Underwent Cerebral Reperfusion Therapy: A Brazilian Cohort Study. Front Aging Neurosci. 2021 Jul 6;13:649902. https://doi.org/10.3389/fnagi.2021.649902
12. Skyrud KD, Vikum E, Hansen TM, Kristoffersen DT, Helgeland J. Hospital Variation in 30-Day Mortality for Patients With Stroke; The Impact of Individual and Municipal Socio-Demographic Status. J Am Heart Assoc. 2019 Jul 16;8(14):e010148. https://doi.org/10.1161/jaha.118.010148
13. Morovatdar N, Thrift AG, Stranges S, Kapral M, Behrouz R, Amiri A, et al. Socioeconomic Status and Long-Term Stroke Mortality, Recurrence and Disability in Iran: The Mashhad Stroke Incidence Study. Neuroepidemiology. 2019;53(1-2):27-31. https://doi.org/10.1159/000494885
14. Pennlert J, Asplund K, Glader EL, Norrving B, Eriksson M. Socioeconomic Status and the Risk of Stroke Recurrence: Persisting Gaps Observed in a Nationwide Swedish Study 2001 to 2012. Stroke. 2017 Jun;48(6):1518-23. https://doi.org/10.1161/strokeaha.116.015643
15. Hansagi H, Romelsjö A, Gerhardsson de Verdier M, Andréasson S, Leifman A. Alcohol consumption and stroke mortality. 20-year follow-up of 15,077 men and women. Stroke. 1995 Oct;26(10):1768-73. https://doi.org/10.1161/01.str.26.10.1768
16. Li L, Xing X, Li Q, Zhang Q, Meng Z. Association between blood glucose level trajectories and 30-day mortality risk in patients with acute ischemic stroke: analysis of the MIMIC database 2001-2019. Diabetol Metab Syndr. 2024 Oct 19;16(1):249. https://doi.org/10.1186/s13098-024-01482-x
17. Huang YW, Yin XS, Li ZP. Association of the stress hyperglycemia ratio and clinical outcomes in patients with stroke: A systematic review and meta-analysis. Front Neurol. 2022 Sep 1;13:999536. https://doi.org/10.3389/fneur.2022.999536
18. Ido MS, Frankel MR, Okosun IS, Rothenberg RB. The impact of IV alteplase on long-term patient survival: The Georgia Coverdell acute stroke registry’s experience. Am J Emerg Med. 2018 Feb;36(2):262-5. https://doi.org/10.1016/j.ajem.2017.07.092
19. Ward C. Impact of alteplase administration time on clinical outcomes in acute ischemic stroke patients. Azusa (CA): Azusa Pacific Univ; 2021.
20. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018 Mar;49(3):e46-110. https://doi.org/10.1161/str.0000000000000158
21. Mehryar H R, Khaffafi B, Shadfar F, Khoshakhlagh H, Rezazadeh F, choobi anzali B. The Potential risk factors of Ischemic stroke incidence and mortality. Int J Res Appl Basic Med Sci. 2019;5(1):50-68.
22. Heo J, Youk TM, Seo KD. Anemia Is a Risk Factor for the Development of Ischemic Stroke and Post-Stroke Mortality. J Clin Med. 2021 Jun 9;10(12):2556. https://doi.org/10.3390/jcm10122556
23. Wang CW, Ma PJ, Wang YY, Yang M, Su LL, Wang S, et al. Serum level of macrophage migration inhibitory factor predicts severity and prognosis in patients with ischemic stroke. Cytokine. 2019 Mar;115:8-12. https://doi.org/10.1016/j.cyto.2018.11.029
24. Sarbazi E, Sarbakhsh P, Savadi Oskooei D, Yazdchi M, Ghaffari-Fam S, Shamshirgaran SM. Factors related to 6-month mortality after the first-ever stroke. J Educ Health Promot. 2018 Sep 14;7:113. https://doi.org/10.4103/jehp.jehp_190_17
25. Suda S, Aoki J, Shimoyama T, Suzuki K, Sakamoto Y, Katano T, et al. Stroke-associated infection independently predicts 3-month poor functional outcome and mortality. J Neurol. 2018 Feb;265(2):370-5. https://doi.org/10.1007/s00415-017-8714-6
26. Ashour W, Al-Anwar AD, Kamel AE, Aidaros MA. Predictors of early infection in cerebral ischemic stroke. J Med Life. 2016 Apr-Jun;9(2):163-9.
27. Avan A, Digaleh H, Di Napoli M, Stranges S, Behrouz R, Shojaeianbabaei G, et al. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017. BMC Med. 2019 Oct 24;17(1):191. https://doi.org/10.1186/s12916-019-1397-3
28. Addo J, Ayerbe L, Mohan KM, Crichton S, Sheldenkar A, Chen R, et al. Socioeconomic status and stroke: an updated review. Stroke. 2012 Apr;43(4):1186-91. https://doi.org/10.1161/strokeaha.111.639732
29. Vivanco-Hidalgo RM, Ribera A, Abilleira S. Association of Socioeconomic Status With Ischemic Stroke Survival. Stroke. 2019 Dec;50(12):3400-7. https://doi.org/10.1161/strokeaha.119.026607
30. Wang IK, Liu CH, Yen TH, Jeng JS, Hsu SP, Chen CH, et al. Cholesterol Levels Are Associated with 30-day Mortality from Ischemic Stroke in Dialysis Patients. J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1349-56. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.02.007
31. Mittal SH, Goel D, Mittal M, Govil T, Mittal S. Identification of mortality-related predictive factors in hospitalized patients with ischemic stroke. Astrocyte. 2015;1:272–6. https://doi.org/10.4103/2349-0977.161613
32. Bager JE, Hjalmarsson C, Manhem K, Andersson B. Acute blood pressure levels and long-term outcome in ischemic stroke. Brain Behav. 2018 Jun;8(6):e00992. https://doi.org/10.1002/brb3.992